Evonik
Keith Parsons is a Senior Scientist at Evonik since September 2022, with prior experience as a Scientist in Process Development at Nektar Therapeutics (November 2021 - June 2022) and as a Scientist focusing on Polymers & Materials at Mirus Bio LLC (August 2018 - November 2021). Keith's academic background includes a PhD in Polymer Science and Engineering from the University of Southern Mississippi (2010 - 2018) and a BS in Chemistry from Millsaps College (2006 - 2010). Research experience includes heavy metal analysis of ancient pottery and the synthesis of covalently linked Vancomycin dimers. Keith also held positions as a Research Assistant at The RANE Center at River Oaks Hospital and as an Undergraduate Researcher at Millsaps College.
This person is not in any offices
Evonik
12 followers
Evonik is a Germany-based specialty chemicals company that operates in four segments: The Nutrition and Care segment produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as nutrition for animal food and healthcare products; the Resource Efficiency segment offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; the Performance Materials segment produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and the Services segment comprises site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at the Company's sites. Its majority shareholder is RAG Stiftung.